A New Frontier in the Fight Against Cancer
Cancer’s challenge and why SPARK is researching it in space?
Cancer’s challenge and why SPARK is researching it in space?
The clear ROI of orbital labs for oncology R&D.
Unlocking Cancer’s Secrets in Microgravity
Why space research is essential, not obsolete, for modern oncology.
Step-by-step guide to launching your first microgravity research mission.
How microgravity enables better drug design and novel formulations.
SPARK Microgravity has successfully completed its integration campaign with Swedish Space Corporation (SSC).
How removing gravity reveals new insights in cancer research.
SPARK Microgravity's co-founders share their space research mission during an interview at Barcelona Deep Tech Week 2025.
SPARK’s presence at Frontiers Science House reflects a broader momentum around the company as it continues to develop its orbital oncology platform.
Real case studies prove ROI of microgravity-enabled pharma innovation.
How cancer's behavior in space reveals new therapeutic targets.
Why 2D and animal models fail and how microgravity bridges translation.
SPARK Microgravity’s leadership engaged with partners including Atmos Space Cargo, Space Cargo Unlimited, and Merck Sharp & Dohme (MSD)
How microgravity enables better drug design and novel therapeutic formulations.
How microgravity reveals truer tumor behavior than traditional models.
SPARK Microgravity announces plans for Europe’s first commercial cancer lab in space at Frontiers Science House in Davos
Meet the startup who won #1 EU Deep Tech Award 2025
Why microgravity transforms biomedical models for personalized medicine breakthroughs.
SPARK Microgravity Completes First Rocket Launch, Marking a Major Milestone Toward Orbital Cancer Research
A beginner-friendly guide to understanding how SPARK Microgravity fits into the future of space.
Allison Bajet, joined an exceptional group of internationally recognized space leaders at Frontiers Science House in Davos for the session “The Space Technology Revolution".
A data-driven look at the market for orbital oncology research.
Two female founders are pioneering the next frontier in oncology.
SPARK Microgravity Brings Orbital Oncology Vision to ORBIT FOR LIFE Roundtable at Roche Diagnostics
Solving "Undruggable" Targets with Perfect Crystals
SPARK Microgravity GmbH has clinched the top honor at the Barcelona Deep Tech Summit 2025, taking home the #1 EU Deep Tech Champion Award.
Solving "Undruggable" Targets with Perfect Crystals
Unlocking Cancer’s Secrets in Microgravity
Cancer’s challenge and why SPARK is researching it in space?
The clear ROI of orbital labs for oncology R&D.
How microgravity enables better drug design and novel therapeutic formulations.
How removing gravity reveals new insights in cancer research.
Two female founders are pioneering the next frontier in oncology.
A data-driven look at the market for orbital oncology research.
A beginner-friendly guide to understanding how SPARK Microgravity fits into the future of space.
Why 2D and animal models fail and how microgravity bridges translation.
How microgravity reveals truer tumor behavior than traditional models.
Step-by-step guide to launching your first microgravity research mission.
Real case studies prove ROI of microgravity-enabled pharma innovation.
How cancer's behavior in space reveals new therapeutic targets.
How microgravity enables better drug design and novel formulations.
Why space research is essential, not obsolete, for modern oncology.
Why microgravity transforms biomedical models for personalized medicine breakthroughs.
From orbit to clinic, let’s launch the future of healthcare, together.
.svg)
